“With the app, we can help keep potentially infectious individuals from exposing other patients or staff in the healthcare system in waiting rooms, emergency rooms, or triage before they are identified and separated.”

ATLANTA (PRWEB)
March 06, 2020

Rimidi, a cloud-based software platform, today announced the launch of its patient-reported outcomes survey app to help limit the spread of COVID-19 in healthcare settings. Currently, the app is in expedited beta testing by select U.S. health systems operating in the regions at the greatest risk of Coronavirus outbreak. Rimidi anticipates general availability of the app before the end of March 2020.

“One of the greatest challenges in China and across other countries that faced early COVID-19 outbreaks has been hospital-based transmission,” said Lucienne Ide, MD, PhD, founder of Rimidi. “With the app, we can help keep potentially infectious individuals from exposing other patients or staff in the healthcare system in waiting rooms, emergency rooms, or triage before they are identified and separated.”

Combatting Coronavirus Spread via Advanced EHR-integrated Technology

Along with their text message appointment reminder, patients are sent a brief COVID-19 screening survey inquiring about current symptoms and recent travel. Integrated within the electronic health record (EHR), patient responses are easily captured and analyzed by clinical teams. The survey respondents demonstrating potential risk of COVID-19 exposure, in accordance with the latest CDC guidelines, are immediately notified with the appropriate next steps of care and treatment options, while the healthcare system is confidentially made aware of the at-risk patient.

Ultimately, the simplicity and accessibility of Rimidi’s screening app will help minimize the spread and impact of COVID-19 in healthcare settings by reducing the number of undiagnosed patients interacting with patients seeking standard care. It will also limit exposure of healthcare staff to potentially infectious patients in settings that are not adequately prepared.

Dr. Ide added, “The need for such a screening app was advocated for in a JAMA article following the Ebola outbreak in 2014. Today, the potential COVID-19 public health emergency reinforces the healthcare industry’s need for interoperability and stronger data-sharing rules to ease the flow of information, which enables rapid deployment of a single application across multiple EHR platforms.”

Rimidi remains in close coordination with the Centers for Disease Control and Prevention and will incorporate new evidence and its evolving guidance into the screening app as it emerges. This may include ongoing remote monitoring and self-reporting by patients in quarantine, among other features.

For more information and to be notified when the app is widely available for healthcare systems, please visit rimidi.com/covid19.

About Rimidi

Rimidi is a cloud-based software platform that enables personalized management of health conditions across populations. Created by doctors, Rimidi avoids the disconnect in connected care by combining patient-generated health data with clinical data from the EHR to drive patient-specific clinical insights and actions. The net effect is a better health system with optimized clinical workflows that enable better decisions, better relationships, better outcomes and ultimately a better healthcare system. For more information, visit rimidi.com and follow us on Facebook, Twitter and LinkedIn.

Media Contact:

Cortney Williams

ARPR, on behalf of Rimidi

cortney@arpr.com

855.300.8209

Share article on social media or email:

Xtalks Life Science Webinars

The criticality and specialized handling needed for each shipment requires seamless execution of a vein-to-vein supply chain throughout the journey, and the manufacturers of these complex therapies must also consider the reliability, quality and cost effectiveness of any solution.

TORONTO (PRWEB)
March 06, 2020

To control and direct the power of a patient’s immune system in order to fight disease is both ground-breaking as well as complicated. While the success of cell and gene therapy strives to become more mainstream and is increasingly the focus of researchers, the longer-term potential requires exploration. Researchers and manufacturers must translate the progress of cell and gene trials into broader programs targeting larger populations. Scalability and manufacturability are two challenges that the industry faces.

Nevertheless, before commercialization, cell and gene therapies encounter many other challenges as they progress towards their goal. The criticality and specialized handling needed for each shipment requires seamless execution of a vein-to-vein supply chain throughout the journey, and the manufacturers of these complex therapies must also consider the reliability, quality and cost effectiveness of any solution.

Join Darren Dasburg, Global Head of Cell Gene Services, Marken and Jeff Stone, Senior Director, Global Program Management, Marken in a live webinar on Thursday, March 19, 2020 at 9am EDT (1pm GMT).

For more information or to register for this event, visit Cell and Gene Therapies – Trends, Supply Chain Challenges and Solutions.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

ABOUT MARKEN

Marken is a wholly owned subsidiary of UPS. Marken is the only patient-centric supply chain organization 100% dedicated to the pharmaceutical and life sciences industries. Marken maintains the leading position for Direct to Patient and Home Health care services, biological sample shipments and offers a state-of-the-art GMP-compliant depot network and logistic hubs in 51 locations worldwide for clinical trial material storage and distribution. Marken’s more than 1,000 staff members manage 85,000 drug and biological shipments every month at all temperature ranges in more than 150 countries. Additional services such as biological kit production, ancillary material sourcing, storage and distribution, shipment lane verification and qualifications, as well as GDP, regulatory and compliance consultancy add to Marken’s unique position in the pharma and logistics industry. http://www.marken.com

To learn more about Xtalks, visit http://xtalks.com.

For information about hosting a webinar, visit http://xtalks.com/why-host-a-webinar/.

Share article on social media or email:

The SAFE App

“Our goal is to empower young people to respect and protect their sexual health. We created a tool to have the conversation about sexual health between partners, while also providing access to easy and affordable testing…our mission is to end the spread and stigma of STDs in our lifetime.”

LOS ANGELES (PRWEB)
March 06, 2020

SAFE Health, a digital healthcare company focused on sexual health, has been selected as a finalist for the 12th annual SXSW Pitch® (formerly SXSW Accelerator) for its debut product, The SAFE App, which lets potential partners verify each others sexual health status and provides the easiest and least expensive way to get tested.

SXSW Pitch is the marquee event of South by Southwest® (SXSW®) Conference & Festivals (March 13 – 22, 2020) Startups Track, where leading startups from around the world showcase some of the most impressive technology innovations to a panel of hand-picked judges and a live audience. Out of the 937 companies that applied to present at SXSW Pitch 2020, SAFE was selected as one of 5 finalists in the Health, Wearables & Wellbeing category.

The event will be held the first weekend of SXSW Conference & Festivals on the fourth floor of the Downtown Hilton Austin, Salon D/E. The event will then culminate with the 2020 SXSW Pitch Awards Ceremony on Sunday evening, March 15, where winning startups from each category and a Best in Show winner will be announced and honored. SAFE and fellow finalists in the Health, Wearables & Wellbeing category will present on March 15th.

“Our goal is to empower young people to respect and protect their sexual health,”said Lauren Weiniger, co-founder of SAFE. “We created a tool to make it easier, and a little less awkward, to have the conversation about sexual health between partners, while also providing access to easy and affordable testing. It’s not about blame or shame, our mission is to end the spread and stigma of STDs in our lifetime.”

According to the CDC, STD rates have reached an all-time high in the U.S. for the fifth year in a row. Dating apps and social networks have played a significant role as they have expanded dating pools, enabling STIs to spread rapidly through diverse populations. The HIPAA-compliant SAFE App is the first real-world, practical solution to addressing what the CDC now calls a “public health crisis.” The app lets people import their medical records from any provider, so they can show their status on their phone (and confirm the status of their partners). The app also lets users schedule affordable testing at 30,000 locations across the country.

“For over a decade, SXSW Pitch has played a pivotal role in…giving promising companies the resources they need to succeed when it matters most and providing high profile exposure,” said SXSW Pitch Event Producer Chris Valentine. “Of the 503 companies who have participated since the competition’s inception, over 75 percent have gone on to secure funding and 16 percent have been acquired.”

For more information about SXSW Pitch and to view the complete list of finalists, visit: https://www.sxsw.com/pitch.

About SAFE App

SAFE App lets people show their verified STD status on their phone, and provides the easiest and least expensive way to get tested and treated. Users can import their medical records for free from any provider, or book testing at over 30,000 locations. SAFE has partnerships with many of the leading players in healthcare, including Quest, Labcorp, and Mayo Clinic. More than an app, SAFE is a movement to end the spread and stigma of STDs in our lifetime.

Download SAFE App here: http://www.safeapp.me

Photo assets can be found here: https://goo.gl/6zs47h

About SXSW

SXSW dedicates itself to helping creative people achieve their goals. Founded in 1987 in Austin, Texas, SXSW is best known for its conference and festivals that celebrate the convergence of the interactive, film, and music industries. An essential destination for global professionals, the event features sessions, showcases, screenings, exhibitions, and a variety of networking opportunities. SXSW proves that the most unexpected discoveries happen when diverse topics and people come together. SXSW 2020 will take place March 13 – 22, 2020. For more information, please visit sxsw.com.

Media Contact:

Bridget Garwood

The SAFE App

301-305-6284

Share article on social media or email:

Charles E. Crutchfield III, M.D.

“I will never rush a patient who may face an unfavorable diagnosis. If I have to choose between compassion and keeping our schedule to the minute, we are going to run late.” – Charles E. Crutchfield III, M.D.

EAGAN, Minn. (PRWEB)
March 06, 2020

Whether replacing a furnace, installing new carpeting, or finding the best hotel for the next trip, chances are most people read online reviews to help make those selections. Online reviews are increasingly used to help find the best doctor, too. Studies show people benefit from learning about other people’s experiences.

“That’s why we are so proud Crutchfield Dermatology has received so many positive patient reviews,” says Charles E. Crutchfield III, MD, Medical Director of Crutchfield Dermatology. “Having over 2,000 people take the time to recount their positive experience at our clinic is one of the greatest honors we could receive.”

Dr. Crutchfield explains that, like any business, the clinic is “far from perfect.” But it’s the commitment to actively working on getting better every day that sets the clinic apart.

“When a review touches on an experience that is ‘less than ideal’ it gives us a chance to improve,” Crutchfield explains.

The emergence of online reviews as a prominent information source for consumers comes with challenges. Online reviews for physicians and other professional industries have an inherent selection bias.

For example, many negative reviews will express dissatisfaction that a medical condition isn’t cured when it’s well-known there is no cure for the disease. In those cases, which are not the fault or responsibility of the physician, there is no way to satisfy the patient.

Likewise, businesses can take the blame for third-party actors. For instance, a patient may feel a medicine costs too much or be upset that their insurance does not cover it. Even though this is beyond the control of the doctor, the patient will attribute the problem to that clinic rather than the health plan denying payment or pharmaceutical company charging the high price.

With over 2,000 verified, positive reviews about the quality of Crutchfield Dermatology’s services, are there any concerns expressed by patients about the clinic?

“Yes, of course,” responds Clinic Manager, Tim Quesnell. “Like all clinics, patients don’t like to wait.”

Whether it stems from sensitivity to the value of time in an increasingly fast-paced world, or some other cause, medical clinics and other service businesses struggle to maximize access to their services while minimizing wait times.

“We work every day to improve the schedule,” Quesnell says. “But medicine is not like the restaurant business. Things come up every clinic, and sometimes patients need extra attention.”

Crutchfield adds, “I will never rush a patient who may face an unfavorable diagnosis. If I have to choose between compassion and keeping our schedule to the minute, we are going to run late. Most people who have to wait when those conditions arise realize that if they were ever in need of a little extra attention, we would give it to them, too.”

But not all people look at commercial experiences with that level of empathy, which is why the 2K mark for positive reviews is so remarkable.

“Most people who have a great result or outcome go on with normal life. They go shopping with friends, run errands, and do other routine things that don’t include writing a review,” explains Darrin Rosha, a Minnesota attorney who works with clients on reputation issues. “People don’t usually run to their computer to express how happy they are. Rather, the desire to vent about a negative experience is far more powerful.”

Because so many patients have positively reviewed Crutchfield Dermatology, a remarkable occurrence in its own right, those reviews and word of mouth among professionals have resulted in over a thousand physicians sending patients Crutchfield Dermatology for dermatologic expertise and care. Although reviews and referrals reflect how Crutchfield Dermatology is a center of excellence and in high demand, there are aspects of the clinic that reviews don’t show.

For instance, many dermatology clinics pass more and more of their patient contact and care to mid-level personnel. Dr. Crutchfield has refused to hire physician assistants or other midlevel providers: He insists on seeing, diagnosing, and treating his patients personally. This commitment to patient care has resulted in the premium care Dr. Crutchfield is known for and fiercely proud of.

“We know we are in demand, and that leads to access challenges. We tell patients if they have a time-sensitive schedule that will not allow them to wait if necessary, we are probably not the right practice for them, Crutchfield continues.

Quesnell adds, “But if a patient demands the highest quality care and the knowledge that they will be seen by a professor of dermatology and one of the best board-certified dermatologists in the country, Crutchfield Dermatology welcomes them with open arms.”

It’s easy to see why Crutchfield Dermatology is so proud to have received over 2,000 verified, authentic positive patient reviews located at http://www.CrutchfieldDermatologyReviews.com

About Charles E. Crutchfield III, M.D.:

Charles E. Crutchfield III, M.D. is a graduate of the Mayo Clinic Medical School and a Clinical Professor of Dermatology at the University of Minnesota Medical School. He currently is the Medical Director of Crutchfield Dermatology in Eagan, (serving the greater Minneapolis-St. Paul area), Minnesota. Dr. Crutchfield is an annual selection of the “Top Doctors” issue of Mpls. St. Paul magazine. He is the only dermatologist to have been selected as a “Best Doctor for Women” by Minnesota Monthly magazine since the inception of the survey. Dr. Crutchfield has been selected as one of the “Best Doctors in America,” an honor awarded to only 4% of all practicing physicians. Dr. Crutchfield is the co-author of a children’s book on sun protection and dermatology textbook. He is a member of the AΩA National Medical Honor Society, an expert consultant for WebMD and CNN, and a recipient of the Karis Humanitarian Award from the Mayo Clinic School of Medicine. Dr. Crutchfield was also given “first a physician” award, Healthcare Hero, 100 most influential healthcare leaders in Minnesota, and one of the Top 100 African –American Newsmakers in the United States by TheGrio, an affiliate of NBC News. https://en.wikipedia.org/wiki/Grio_Awards